15% hike in Utah colon cancer linked to delayed pandemic screenings 

Murray, Utah-based Intermountain Healthcare physicians are tying a 15 percent increase in colon cancer cases to a 50 percent drop in colon cancer screenings since the beginning of the pandemic, according a March 3 Standard Examiner report.

Advertisement

During a news conference to encourage Utah residents to stop delaying treatment, one Intermountain gastroenterologist, Nathan Merriman, MD, said, “I think it’s just been overwhelming with everything going on with COVID-19. There’s been a lot of postponement of screening, but with the drop in COVID patients, it is safe to come back and, in fact, I’m encouraging it, especially with this month being Colon Cancer Awareness Month.”

Dr. Merriman said many people have been hesitant to come in for regular screenings during the pandemic, and some of his patients with rectal bleeding had waited four to nine months before coming to see him. 

“Way too long to wait,” he told the Examiner.

Colorectal cancer is the second-leading cause of cancer-related death in the U.S. in men and women combined, according to the American Cancer Society.

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.